Schools that provide prevention education, insecticide-treated nets and antimalarial treatment, in regions where malaria is highly seasonal, could reduce the risk of schoolchildren developing anemia and improve their cognitive performance, according to new research by the London School of Hygiene & Tropical Medicine.
EASL raises serious concerns over a Cochrane systematic review and questions conclusions in an editorial published today in Journal of Hepatology.
Medicinal payload could be delivered by engineered RNAs that can be controlled by a billion year-old 'genetic fossil' found in all cells.
A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine. The findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.
A new study has found that flu evolution within some individuals can hint at the virus's eventual evolutionary course worldwide.
Scientists at UC Berkeley and UC Riverside have demonstrated a way to edit the genome of disease-carrying mosquitoes that brings us closer to suppressing them on a continental scale.
Scientists at the Morgridge Institute for Research have, for the first time, imaged molecular structures vital to how a major class of viruses replicates within infected cells. The research uses pioneering cryo-electron tomography to reveal the complex viral replication process in vivid detail, opening up new avenues to potentially disrupt, dismantle or redirect viral machinery.
Researchers from Kumamoto University in Japan have found that a human endogenous retrovirus family, HERV-K, interferes with the replication and infectivity of HIV-1.
A phase I clinical trial conducted by Emory University in collaboration with researchers from the Georgia Institute of Technology has found that influenza vaccination using Band-Aid-like patches with dissolvable microneedles was safe and well-tolerated by study participants, was just as effective in generating immunity against influenza, and was strongly preferred by study participants over vaccination with a hypodermic needle and syringe.
A National Institutes of Health-funded study led by a team at the Georgia Institute of Technology and Emory University has shown that an influenza vaccine can produce robust immune responses and be administered safely with an experimental patch of dissolving microneedles. The method is an alternative to needle-and-syringe immunization; with further development, it could eliminate the discomfort of an injection as well as the inconvenience and expense of visiting a flu clinic.